| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.9M | -11.7% |
| Cost of Revenue | $13.0M | -8.2% |
| Gross Profit | $20.9M | -13.8% |
| R&D Expense | $20.5M | -21.9% |
| SG&A Expense | $18.5M | +8.4% |
| Operating Income | -$33.2M | +19.7% |
| Pre-tax Income | -$32.3M | +17.2% |
| Income Tax | $31K | -29.5% |
| Net Income | -$32.3M | +17.2% |
| EPS (Basic) | -$1.49 | +18.6% |
| EPS (Diluted) | -$1.49 | +18.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.8M | -20.6% |
| Short-term Investments | $3.0M | -81.4% |
| Accounts Receivable | $6.5M | +1.6% |
| Current Assets | $21.3M | -45.7% |
| Total Assets | $53.0M | -30.1% |
| Current Liabilities | $8.4M | -8.6% |
| Total Liabilities | $12.7M | -11.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.8M | +55.7% |
| Capital Expenditures | $570K | +168.9% |
| Investing Cash Flow | $12.1M | +207.2% |
| Financing Cash Flow | -$2.9M | -110.1% |
| Free Cash Flow | -$12.3M | +53.9% |
| Stockholders' Equity |
| $40.2M |
| -34.4% |